Christian Clasby, MD
Pain Medicine · New Albany, INNPI 1841433380
Payments from drug & device makers
Across 174 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$621
- Collegium Pharmaceutical, Inc.$372
- Azurity Pharmaceuticals, Inc.$252
- IBSA Pharma Inc.$219
- Protega Pharmaceutials Inc$161
- Takeda Pharmaceuticals U.S.A., Inc.$151
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,06099%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 36 | $621 |
| Collegium Pharmaceutical, Inc. | 24 | $372 |
| Azurity Pharmaceuticals, Inc. | 15 | $252 |
| IBSA Pharma Inc. | 12 | $219 |
| Protega Pharmaceutials Inc | 4 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $151 |
| Arbor Pharmaceuticals, Inc. | 10 | $143 |
| AbbVie | 6 | $130 |
| Pfizer | 6 | $129 |
| Hikma Pharmaceuticals USA | 6 | $101 |
| Boston Scientific | 3 | $80 |
| AstraZeneca | 6 | $77 |
| Abbott | 3 | $73 |
| Pacira Therapeutics, Inc. | 4 | $62 |
| Avanos Medical | 2 | $59 |
| Vertex | 3 | $58 |
| Daiichi Sankyo Inc. | 4 | $56 |
| Biodelivery Sciences International, Inc. | 3 | $52 |
| Averitas Pharma Inc. | 1 | $46 |
| Saluda Medical Americas, Inc. | 1 | $32 |
| Si-bone, Inc. | 2 | $29 |
| Eisai Inc. | 2 | $23 |
| Tonix Medicines, Inc. | 1 | $20 |
| Pernix Therapeutics Holdings, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Biotronik NRO, Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
| Amgen | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| MDD US Operations, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RELISTOR$122
How this compares
$3,084 in reported general payments places this provider in the 45th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 88 | $80,025 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,980 | $45,045 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,434 | $44,226 |
| Xtampza ErOxycodone Myristate | 54 | $43,941 |
| HorizantGabapentin Enacarbil | 33 | $33,038 |
| Nucynta ErTapentadol Hcl | 12 | $27,431 |
| Pregabalin | 663 | $26,971 |
| Oxycodone Hcl | 755 | $22,467 |
| Hysingla ErHydrocodone Bitartrate | 26 | $22,392 |
| MovantikNaloxegol Oxalate | 34 | $19,150 |
| LyricaPregabalin | 26 | $18,961 |
| Gabapentin | 1,058 | $14,688 |
| Morphine Sulfate ErMorphine Sulfate | 441 | $13,707 |
| LicartDiclofenac Epolamine | 16 | $12,233 |
| Fentanyl | 79 | $11,313 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Belbuca | $372 | $78,85377 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $143 | $33,03833 claims |
| PfizerLyrica | $129 | $18,96126 claims |
| IBSA Pharma Inc.Licart | $219 | $12,23316 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate, Buprenorphine | $101 | $6,613146 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 128 pain medicine providers in Indiana.
Other pain medicine in New Albany
- Nirav PatelNew Albany$7K
- Patricia HabimanaNew Albany$4K
- Meredith LanghorstFishers$1.5M
- Derron WilsonCarmel$1.3M
- Jonathan GentileCarmel$1.1M
- Kevin MacadaegCarmel$866K
- Robert FunkCarmel$417K
- Andrew TrobridgeMuncie$266K
- Abhishek DasMishawaka$186K
- Rajiv TewariFishers$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.